高级搜索
谭文勇, 申维玺. 抗肿瘤药物相关性心血管疾病的发生机制研究进展[J]. 肿瘤防治研究, 2018, 45(11): 837-840. DOI: 10.3971/j.issn.1000-8578.2018.18.0422
引用本文: 谭文勇, 申维玺. 抗肿瘤药物相关性心血管疾病的发生机制研究进展[J]. 肿瘤防治研究, 2018, 45(11): 837-840. DOI: 10.3971/j.issn.1000-8578.2018.18.0422
TAN Wenyong, SHEN Weixi. Pathogenesis of Anti-cancer Drugs-induced Cardiovascular Diseases: The State-of-the-art[J]. Cancer Research on Prevention and Treatment, 2018, 45(11): 837-840. DOI: 10.3971/j.issn.1000-8578.2018.18.0422
Citation: TAN Wenyong, SHEN Weixi. Pathogenesis of Anti-cancer Drugs-induced Cardiovascular Diseases: The State-of-the-art[J]. Cancer Research on Prevention and Treatment, 2018, 45(11): 837-840. DOI: 10.3971/j.issn.1000-8578.2018.18.0422

抗肿瘤药物相关性心血管疾病的发生机制研究进展

Pathogenesis of Anti-cancer Drugs-induced Cardiovascular Diseases: The State-of-the-art

  • 摘要: 在肿瘤患者的死亡原因中,恶性肿瘤本身导致的死亡为首位原因,其次为抗肿瘤治疗相关性心脏疾病。肿瘤和心血管疾病作为最主要的慢性非传染性疾病,抗肿瘤药物治疗可能导致多种心血管事件,并日益受到关注。抗肿瘤药物包括化疗药物、分子靶向药物和免疫检查点抑制剂,多数可引起不同程度的心血管疾病,称为抗肿瘤药物治疗相关性心脏病。本文重点讨论各种抗肿瘤药物引发心血管疾病的发病机制,为肿瘤研究和临床实践提供参考。

     

    Abstract: Among the death cause of cancer, the malignancies themselves were the top cause and the anti-cancer therapy-associated heart cardiovascular disease was the second one. Both cancer and cardiovascular disease are the common chronic non-communicable diseases. And various anti-cancer drugs would inevitably induce some cardiovascular events. These anti-cancer drugs include the traditional cytotoxic agents, molecularly targeted drugs and immunological checkpoint inhibitors. In this review, the possible pathogenesis of anti-cancer drug-induced cardiovascular diseases will be discussed, which will be useful for the cancer research and oncological clinical practice.

     

/

返回文章
返回